Zhiqiang Han - Search Results

Year	Number of Results
2003	1
2004	4
2005	4
2006	6
2007	6
2008	4
2009	4
2010	3
2011	9
2012	5
2013	11
2014	8
2015	7
2016	12
2017	3
2018	9
2019	7
2020	18
2021	26
2022	29
2023	25
2024	14

1

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends.

Sun Q, Hong Z, Zhang C, Wang L, Han Z, Ma D. Sun Q, et al. Among authors: han z. Signal Transduct Target Ther. 2023 Aug 28;8(1):320. doi: 10.1038/s41392-023-01522-4. Signal Transduct Target Ther. 2023. PMID: 37635168 Free PMC article. Review.

2

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment.

Li S, Wang L, Wang Y, Zhang C, Hong Z, Han Z. Li S, et al. Among authors: han z. J Hematol Oncol. 2022 Oct 17;15(1):147. doi: 10.1186/s13045-022-01360-x. J Hematol Oncol. 2022. PMID: 36253861 Free PMC article. Review.

3

PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma.

Hu X, He Y, Han Z, Liu W, Liu D, Zhang X, Chen L, Qi L, Chen L, Luo Y, Li Q, Chen P, Wu Q, Zhu X, Guo H. Hu X, et al. Among authors: han z. Cell Death Dis. 2022 Nov 29;13(11):1010. doi: 10.1038/s41419-022-05448-7. Cell Death Dis. 2022. PMID: 36446769 Free PMC article.

4

Foetal microchimerism occurs in pigs.

Wang Z, Ren J, Han Z, Wang J, Gu S, Zhou Y, Han Z, Zhai Y, Zhang S, An X, Yu D, Hu Z, Hai T, Li Z. Wang Z, et al. Among authors: han z. Cell Prolif. 2022 Nov;55(11):e13333. doi: 10.1111/cpr.13333. Epub 2022 Sep 8. Cell Prolif. 2022. PMID: 36073746 Free PMC article. No abstract available.

5

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.

Hao Z, Li R, Wang Y, Li S, Hong Z, Han Z. Hao Z, et al. Among authors: han z. Biomark Res. 2021 Oct 24;9(1):77. doi: 10.1186/s40364-021-00333-5. Biomark Res. 2021. PMID: 34689842 Free PMC article. Review.

6

Long-read sequencing reveals oncogenic mechanism of HPV-human fusion transcripts in cervical cancer.

Liu M, Han Z, Zhi Y, Ruan Y, Cao G, Wang G, Xu X, Mu J, Kang J, Dai F, Wen X, Zhang Q, Li F. Liu M, et al. Among authors: han z. Transl Res. 2023 Mar;253:80-94. doi: 10.1016/j.trsl.2022.09.004. Epub 2022 Oct 9. Transl Res. 2023. PMID: 36223881

7

Superresolution Fluorescence Microscopy of Platelet Subcellular Structures as a Potential Tumor Liquid Biopsy.

Xu P, Deng H, Hong Z, Zhong S, Chen F, Wang L, Wang Z, Mei Y, Luo Z, He Z, Li H, Gan C, Zhang H, Ma Y, Han Z, Zhang YH. Xu P, et al. Among authors: han z. Small Methods. 2023 Oct;7(10):e2300445. doi: 10.1002/smtd.202300445. Epub 2023 Jun 22. Small Methods. 2023. PMID: 37349902

8

Effectiveness and safety of nab-paclitaxel and platinum as first-line chemotherapy for ovarian cancer: a retrospective study.

Wang L, Li S, Zhu D, Qin Y, Wang X, Hong Z, Han Z. Wang L, et al. Among authors: han z. J Gynecol Oncol. 2023 Jul;34(4):e44. doi: 10.3802/jgo.2023.34.e44. Epub 2023 Feb 6. J Gynecol Oncol. 2023. PMID: 36807747 Free PMC article.

9

Macrophage, the potential key mediator in CAR-T related CRS.

Hao Z, Li R, Meng L, Han Z, Hong Z. Hao Z, et al. Among authors: han z. Exp Hematol Oncol. 2020 Jul 10;9:15. doi: 10.1186/s40164-020-00171-5. eCollection 2020. Exp Hematol Oncol. 2020. PMID: 32665874 Free PMC article. Review.

10

Cervical cancer heterogeneity: a constant battle against viruses and drugs.

Sun Q, Wang L, Zhang C, Hong Z, Han Z. Sun Q, et al. Among authors: han z. Biomark Res. 2022 Nov 17;10(1):85. doi: 10.1186/s40364-022-00428-7. Biomark Res. 2022. PMID: 36397138 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

190 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year